Comparing Ventas (VTR) & HCP (NYSE:HCP)

Ventas (NYSE: VTR) and HCP (NYSE:HCP) are both large-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability.

Insider & Institutional Ownership

88.6% of Ventas shares are held by institutional investors. Comparatively, 88.9% of HCP shares are held by institutional investors. 1.3% of Ventas shares are held by company insiders. Comparatively, 0.2% of HCP shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Ventas and HCP’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ventas 20.08% 6.31% 2.81%
HCP 32.16% 9.96% 4.19%

Dividends

Ventas pays an annual dividend of $3.10 per share and has a dividend yield of 4.7%. HCP pays an annual dividend of $1.48 per share and has a dividend yield of 5.1%. Ventas pays out 157.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. HCP pays out 102.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. HCP has raised its dividend for 6 consecutive years. HCP is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Ventas and HCP, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ventas 3 7 0 0 1.70
HCP 1 14 2 0 2.06

Ventas presently has a consensus price target of $62.33, suggesting a potential downside of 5.73%. HCP has a consensus price target of $32.69, suggesting a potential upside of 13.32%. Given HCP’s stronger consensus rating and higher probable upside, analysts plainly believe HCP is more favorable than Ventas.

Volatility & Risk

Ventas has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Comparatively, HCP has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.

Earnings & Valuation

This table compares Ventas and HCP’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Ventas $3.52 billion 6.69 $1.88 billion $1.97 33.56
HCP $2.02 billion 6.70 $1.17 billion $1.45 19.90

Ventas has higher revenue and earnings than HCP. HCP is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

Summary

HCP beats Ventas on 12 of the 17 factors compared between the two stocks.

About Ventas

Ventas, Inc. is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses. In its senior living operations segment, it invests in seniors housing communities throughout the United States and Canada and engages independent operators to manage those communities. In its office operations segment, the Company primarily acquires, owns, develops, leases and manages medical office buildings (MOBs) and life science and innovation centers throughout the United States.

About HCP

HCP, Inc. is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities. Its Life science properties contain laboratory and office space for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations. Its Medical office buildings contain physicians’ offices and examination rooms, and may include pharmacies, hospital ancillary service space and outpatient services. As of December 31, 2016, it had interests in and managed 15 hospitals, 61 care homes in the United Kingdom and five post-acute/skilled nursing facilities.

What are top analysts saying about Ventas Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Ventas Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit